Skip to content

FidoCure®

YC W18 · Active · FidoCure® is the leader in Precision Medicine for Canine Oncology.

Competitors

Adjacent

Also from W18

All of W18

About FidoCure®

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!

YC batch
W18 · Winter 2018
Status, per YC
Active
Category
Other
Team size
14
Location
San Francisco, CA, USA; Palo Alto, CA, USA; Remote
Checked
33m ago

YC tags: Oncology

FidoCure® in W18: 146 companies, 25% AI

FidoCure®: questions

Which YC batch was FidoCure® in?

FidoCure® was in Y Combinator's Winter 2018 batch (W18).

Is FidoCure® still active?

Y Combinator lists FidoCure® as active.

Where is FidoCure® based?

FidoCure® lists San Francisco, CA, USA; Palo Alto, CA, USA; Remote as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.